• Careers
  • Contact Us
Ambrx
  • About
    • Leadership
  • Technology
    • Enhanced Antibody Drug Conjugates
    • Expanded Genetic Code Technology
    • Publications
    • Intellectual Property
  • Pipeline
    • Our Pipeline
    • ARX788
    • ARX517
    • ARX305
    • Partners
  • Partners
  • Clinical Trials
    • Active Studies
    • Scientific Presentations
    • Expanded Access Program
  • Resources
    • October 11, 2023 Reorganization Merger Form 8937
  • Menu Menu

ARX517 Preclinical ESMO 2023 abstract

ARX517 Preclinical ESMO 2023 abstract

October 14, 2023
Share this entry
  • Share on Facebook
  • Share on X
  • Share on LinkedIn
  • Share by Mail
/wp-content/uploads/Ambrx_2023-Fullcolor-RGB-1030x228.png 0 0 eallison /wp-content/uploads/Ambrx_2023-Fullcolor-RGB-1030x228.png eallison2023-10-14 23:11:242023-10-14 23:11:24ARX517 Preclinical ESMO 2023 abstract

Copyright © 2025 Ambrx. All Rights Reserved | Privacy | Site Map | Terms of Use

Scroll to top Scroll to top Scroll to top